A human tracheobronchial epithelial tissue airway injury and remodeling (hTET-AIR) NAM for assessing epithelial pathology: From goblet cell hyperplasia to squamous metaplasia.
Publication Year:
2026
PubMed ID:
43022229
Funding Grants:
Scientific Abstract:
New Approach Methodologies (NAMs) are increasingly used to evaluate the respiratory toxicity of inhaled chemicals. Building on established methods for culturing organotypic human tracheobronchial epithelial tissue (hTET) at the air-liquid-interface, we introduce hTET-AIR (human Tracheobronchial Epithelial Tissue-Airway Injury and Remodeling), a pathology-focused NAM that pairs this established tissue and exposure platform with a predefined panel of quantitative endpoints for airway remodeling. The endpoint panel assesses MUC5AC (mucin), ciliary coverage and height, involucrin (squamous cell marker), nuclear orientation, and epithelial thickness to quantify secretory and squamous pathological changes over time. In an initial application of hTET-AIR, hTETs received clean air or NJOY(R) Ace electronic cigarette aerosol at one or five puffs daily for up to three weeks. Involucrin induction began early, in parallel with increasing MUC5AC. At one puff daily, MUC5AC continued to increase through week three; at five puffs daily, it peaked at week two and returned to control levels by week three. Across the three-week exposure, involucrin expression and the proportion of horizontally oriented nuclei increased, while ciliary coverage, ciliary height, and epithelial thickness decreased, with changes generally more pronounced in the five puff group. The MUC5AC kinetics indicate that secretory remodeling overlapped with squamous remodeling, and by week three both exposure groups exhibited hallmark features of squamous metaplasia. Chemical characterization of the generated and deposited aerosol quantified nicotine, propylene glycol, vegetable glycerin, and flavor chemicals, with deposited nicotine concentrations within ranges previously reported in human airway models and airway secretions following tobacco-product exposure. Together, these findings demonstrate that hTET-AIR resolves dose- and time-dependent pathological airway remodeling and show that repeated NJOY(R) Ace aerosol exposure can drive squamous metaplasia in differentiated human tracheobronchial epithelium, with potential application of this NAM to other inhaled test materials.